CAR T-lymphocytes targeting B7-H3 were found to reduce the tumor size in pancreatic ductal adenocarcinoma, ovarian cancer, and neuroblastoma without evident toxicity [113]. This evidence concerns the gene CD276 and pancreatic ductal adenocarcinoma.